Fintel vs Dataroma: Multi-Signal Subscription or Free Curated List?

Fintel and Dataroma sit about as far apart on the product spectrum as two "track institutional investors" tools can get — one is a paid platform aggregating six-plus different regulatory and market data types, the other is a free, hand-curated list of about 83 famous investors maintained by one person. If you've found yourself considering both, it's worth being clear about why they're not really substitutes for each other.

Quick comparison

	Fintel	Dataroma
Coverage	13F, 13D/G, NPORT (funds/ETFs), UK disclosures, short interest, options flow	~83 curated "superinvestor" 13F portfolios
Cost	Bronze $14.95/mo, Silver $29.75/mo, Gold $95/mo	Free
Data verification	Automated ingestion across multiple regulatory sources	Manually checked against EDGAR by the operator
Search any institution	Yes (13F portion)	No — curated list only
Short interest / options flow	Yes	No
Public API	Yes (paid)	No
Proprietary scoring	Fintel Score	None (raw holdings tables)
Site design	Feature-dense, modern	Minimalist, ad-light

(Pricing and feature details reflect what's publicly listed on each site as of this writing — check current details before deciding.)

What Dataroma actually gets right

Dataroma does one thing and does it well: a clean, trustworthy, manually-verified view of what roughly 83 well-known value investors are holding, updated each quarter as 13F filings land. No subscription, no tiers to climb, no cross-selling — if your question is specifically "what is Warren Buffett's or Bill Ackman's portfolio doing this quarter," this is arguably the fastest and most reliable free path to the answer, and it's been reliable for a long time under one operator's manual quality control.

What Fintel actually gets right

Fintel is built for a fundamentally different question: not "what is this famous investor doing," but "what does the fuller picture around this specific stock look like right now, across several regulatory and market data types at once." Short interest, options flow, 13D/G activist stakes, NPORT fund data, UK disclosures — none of that exists in Dataroma at all, curated or otherwise. If you're assessing squeeze risk, reading options positioning, or trying to see activist pressure building on a stock alongside its institutional ownership, Fintel is doing something in a completely different category from a curated 13F list.

These aren't really competing for the same use case

It's tempting to line these up feature-by-feature, but the more honest framing is that they answer different questions for different people. Dataroma is for someone who already knows which handful of famous investors they care about and wants a clean read on them, for free. Fintel is for someone doing broader, more current-events-driven research on a specific stock or sector, who needs several different data types synthesized in one place, and is willing to pay for that synthesis. Someone whose actual need is Dataroma's use case isn't going to get meaningfully more value from Fintel's short interest or options data — it's just not the question they're asking. And someone whose need is Fintel's use case won't find Dataroma useful at all, since it doesn't track the institution or data type they're after in the first place.

What this means for your wallet

If your actual research question fits inside "track a short list of famous value investors," there's no reason to pay Fintel's $14.95–95/month for that specific task — Dataroma answers it for free, and better, since it's purpose-built for exactly that. If your question involves short interest, options flow, or synthesizing multiple filing types on a stock that isn't held by one of Dataroma's ~83 tracked managers, Dataroma has no path to an answer at any price, and Fintel's subscription is the actual cost of getting one. The two tools rarely compete for the same dollar, which is a slightly unusual dynamic in a "vs" comparison post — normally you're weighing genuine substitutes, but here you're mostly just identifying which bucket your actual question falls into.

Two concrete scenarios that show the split clearly

Scenario one: you want to know what Charlie Munger's old fund or Seth Klarman's Baupost Group did last quarter. That's Dataroma's exact use case — free, fast, clean, done. Paying Fintel anything for this specific question would be paying for capability you don't need; none of Fintel's short interest, options, or multi-filing-type data makes this particular answer any better or faster.

Scenario two: you're watching a small-cap that's been rumored to have a large short position, and you want to see options market positioning, recent 13D/G activist filings, and institutional 13F activity together to form a view on whether a squeeze setup is developing. Dataroma can't help at all here — it doesn't track short interest or options data at any depth, and if the stock isn't held by one of its ~83 curated managers, it won't even show up in the 13F portion either. This is squarely Fintel's territory, and it's the kind of synthesis work that would otherwise require checking three or four separate sources by hand.

These two scenarios aren't edge cases chosen to make a point — they're close to the actual center of what each tool's typical user is doing. If your research consistently looks more like scenario one, Fintel's subscription buys you very little. If it consistently looks like scenario two, Dataroma was never going to be relevant regardless of price, since "free" doesn't help if the tool structurally can't answer the question.

What neither tool does

Neither Fintel nor Dataroma tracks Form 4 corporate insider trading or congressional STOCK Act disclosures — both are focused on institutional-level filings and (in Fintel's case) market signals, not personal trading by executives, directors, or lawmakers. If either of those matters to your research, you'll need a separate tool regardless of which of these two fits your primary use case — free options like AlphaSMO cover both, alongside a 13F institutional dataset, though without Fintel's short interest/options coverage or Dataroma's curated simplicity.

If you're genuinely unsure which bucket you're in

A reasonable way to find out cheaply: start with Dataroma, since it costs nothing and takes a few minutes. If it answers your question, you're done, and there was never a reason to pay Fintel anything for this particular need. If Dataroma comes up empty — the investor or institution you care about isn't on its list, or the question is really about short interest, options flow, or synthesizing several filing types — that gap is your actual signal to look at Fintel's Bronze tier, not a general instinct that "more data must be better." The point of running this cheap test first isn't frugality for its own sake; it's that the two tools are different enough in what they cover that guessing which one you need without checking tends to waste either money or time.

A few quick questions people ask

Is Fintel's data more accurate than Dataroma's, since it's paid? Not necessarily — Dataroma's manual verification against EDGAR is a genuine quality control step for its narrower scope, while Fintel's automation covers far more ground but relies more heavily on parsing accuracy at scale. Different tradeoffs, not a strict better-or-worse.

Could Dataroma ever add short interest or options data? No indication of that, and it would be a significant departure from the site's long-standing, deliberately narrow focus.

Is Fintel's cheapest tier enough, or do I need Silver/Gold? Bronze gets you real access, but a meaningful amount of the cross-referencing value people actually want Fintel for tends to live in the higher tiers — check the current feature breakdown before assuming Bronze covers your specific need.

Is there a free way to search the broader 13F institutional universe, if I need more than Dataroma's curated list but don't need Fintel's short interest/options data? Yes — sites like AlphaSMO index the fuller 13F filer set for free, without Fintel's broader multi-signal coverage but without a subscription either.